home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Cancer biotech TRACON Pharmaceuticals files for a $58 million IPO
Cancer biotech TRACON Pharmaceuticals files for a $58 million IPO
Post navigation
Previous Post
Previous
MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
Next Post
Next
TRACON Pharmaceuticals Announces Pricing of Initial Public Offering